We have to break the monopoly pricing power of the drug corporations. We must change the laws to restore competitive pricing and speed generics to market. Prices for drugs should be based on the value they provide to patients. And we need transparency on pricing from the drug companies and the pharmacy benefit insurers so we can see who is making how much off of the suffering of people fighting deadly diseases.